Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Core Laboratories Inc.

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Cisco Systems (CSCO – Research Report) and Cellebrit...

Analysts Are Bullish on These Technology Stocks: Cisco Systems (CSCO), Cellebrite DI (CLBT)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Cellebrite DI (CLBT – Research Report) and Urgent.ly...

Analysts’ Top Technology Picks: Cellebrite DI (CLBT), Urgent.ly Inc (ULY)

Cellebrite Di Ltd. ( ($CLBT) ) has released its Q3 earnings. Here is a breakdown of the information Cellebrite Di Ltd. presented to its investors. ...

Cellebrite Reports Strong Q3 2025 Financial Results

ANGLE plc ( ($GB:CLBX) ) has shared an update. CelLBxHealth plc has announced its intention to raise approximately £6 million to extend its cash ru...

Current Quarter	$0.2	Next Quarter	$0.18
Current Year	$0.74	Next Year	$0.81
QoQ Growth	-10.0%	YoY Growth	+9.5%
3Y EPS CAGR	+15.0%	Target Price	$13.67
Consensus	Buy	Upside	-7.1%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CLB	$14.72	+5.98%	564.91K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CLB	$14.72	+6.0%	564.91K
3
4
5
6

CLB

CLB

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Core Laboratories Inc. Data in Excel

Get Core Laboratories Inc. Data in Excel